CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays
-
Oct 01 2015
-
-
Source: PLoS One. 10(10).
[PDF-8.51 MB]
Details:
-
Alternative Title:PLoS One
-
Personal Author:
-
Description:Currently, a number of assays measure Orthopoxvirus neutralization with serum from individuals, vaccinated against smallpox. In addition to the traditional plaque reduction neutralization test (PRNT), newer higher throughput assays are based on neutralization of recombinant vaccinia virus, expressing reporter genes such as β-galactosidase or green fluorescent protein. These methods could not be used to evaluate neutralization of variola virus, since genetic manipulations of this virus are prohibited by international agreements. Currently, PRNT is the assay of choice to measure neutralization of variola virus. However, PRNT assays are time consuming, labor intensive, and require considerable volume of serum sample for testing. Here, we describe the development of a high-throughput, cell-based imaging assay that can be used to measure neutralization, and characterize replication kinetics of various Orthopoxviruses, including variola, vaccinia, monkeypox, and cowpox.
-
Subjects:
-
Source:
-
Pubmed ID:26426117
-
Pubmed Central ID:PMC4591290
-
Document Type:
-
Volume:10
-
Issue:10
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
Supporting Files
-
jpeg
gif
jpeg
gif
jpeg
gif
jpeg
gif
jpeg
gif 
txt
jpeg
gif
jpeg
txt
gif
jpeg
gif
jpeg
jpeg
jpeg
gif
jpeg
gif
jpeg
gif
